Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Kiora Pharmaceuticals (KPRX) Notes Payables (2020)

Kiora Pharmaceuticals' Notes Payables history spans 1 years, with the latest figure at $212281.0 for Q4 2020.

  • For Q4 2020, Notes Payables changed N/A year-over-year to $212281.0; the TTM value through Dec 2020 reached $212281.0, changed N/A, while the annual FY2020 figure was $212281.0, N/A changed from the prior year.
  • Notes Payables reached $212281.0 in Q4 2020 per KPRX's latest filing.
  • In the past five years, Notes Payables ranged from a high of $212281.0 in Q4 2020 to a low of $212281.0 in Q4 2020.